Effects of the protease inhibitor antipain on cell malignant transformation.
BACKGROUND
Several natural products have been found to exhibit a chemopreventive activity both in in vivo and in vitro experimental systems. Among them, protease inhibitors seem to play a key role in the regulation of growth and phenotypic expression of transformed cells as well as in the regulation of the late events of carcinogenesis. We evaluated the effect of antipain (AP), a natural protease inhibitor, on chemically induced BALB/c 3T3 cell transformation, on invasion and chemotactic motility of transformed cells and on their gelatinase expression.


METHODS
BALB/c 3T3 cells were plated and exposed to 2.5 micrograms/ml 3-MCA or 50 micrograms/ml, 1,2-DBE. The effect of a non-cytotoxic dosage of AP (10 microM) was studied by: a) pretreating cells with AP for 48 hours before the carcinogen exposure; b) adding AP simultaneously to the carcinogen treatment; c) chronic addition of AP at each medium change throughout the experimental duration. The effectiveness of the treatment was analysed as the ability to reduce or inhibit the occurrence of transformed foci. Modulation of the invasive phenotype by anti-transforming dosages of AP was evaluated by in vitro Matrigel invasion assay. Gelatin zymography was performed in order to assess AP regulation of proteolytic enzymes, such as metalloproteases, involved in invasion and metastasis.


RESULTS
AP treatment can reduce the transformation rate both in 3-MCA- and 1,2-DBE-initiated cells. Its effectiveness depends on the administration schedule, and chronic addition seems to be the most effective treatment. The concentration of AP, which is effective in the antitransformation assay, is not able to significantly affect the migration and invasion of chemically transformed cells or their gelatinase activity.


CONCLUSIONS
AP can suppress chemically induced BALB/c 3T3 cell transformation through mechanisms which do not involve modulation of the invasive phenotype.
Vaccari
M
M
Istituto Nazionale per la Ricerca sul Cancro, Genova, Biotechnology Satellite Unit, Bologna, Italy. m.vaccari@istbiotech.it
Argnani
A
A
Horn
W
W
Silingardi
P
P
Giungi
M
M
Mascolo
M G
MG
Bartoli
S
S
Grilli
S
S
Colacci
A
A
D016475:3T3 Cells; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D000976:Antipain / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D051379:Mice; D011480:Protease Inhibitors / Q000494:pharmacology*
D016588:Anticarcinogenic Agents; D011480:Protease Inhibitors; D000976:Antipain